3.04
Finanzdaten der Cumberland Pharmaceuticals Inc-Aktie (CPIX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
64.95%
13.68
|
8.2924 | 10.84 | 11.71 | 10.44 |
| Cost Of Revenue |
126.68%
2.2413
|
0.9888 | 2.0114 | 1.4257 | 1.9765 |
| Gross Profit |
56.60%
11.44
|
7.3036 | 8.826 | 10.29 | 8.4591 |
|
|
46.72%
15.05
|
10.26 | 11.58 | 10.42 | 12.28 |
| Interest Income/Expense |
2.96%
0.1129
|
0.1097 | 0.1095 | 0.1638 | 0.2233 |
| Benefits Costs and Expenses |
47.51%
15.11
|
10.24 | 11.57 | 10.46 | 12.34 |
| Costs And Expenses |
47.28%
15.11
|
10.26 | 11.58 | 10.42 | 12.34 |
| Operating Income/Loss |
30.23%
-1.3712
|
-1.9653 | -0.7475 | 1.2919 | -1.842 |
| Income/Loss From Continuing Operations Before Tax |
26.49%
-1.4286
|
-1.9434 | -0.7295 | 1.2539 | -1.9016 |
| Income Tax Expense/Benefit |
309.96%
0.0232
|
0.00567 | 0.00567 | 0.00567 | -0.057 |
| Income/Loss From Continuing Operations After Tax |
26.70%
-1.4286
|
-1.949 | -0.7352 | 1.2482 | -1.9016 |
|
|
26.70%
-1.4286
|
-1.949 | -0.7352 | 1.2482 | -1.9016 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
104.66%
-0.017
|
-0.00828 | 0.00553 | -0.00888 | 0.00218 |
| Basic Average Shares |
100.66%
-0.0993
|
14.96 | 14.96 | 14.94 | -0.0292 |
| Diluted Average Shares |
100.66%
-0.0993
|
14.96 | 14.96 | 15.26 | -0.0292 |
| Basic Earnings Per Share |
30.77%
-0.09
|
-0.13 | -0.05 | 0.08 | -0.14 |
| Diluted Earnings Per Share |
30.77%
-0.09
|
-0.13 | -0.05 | 0.08 | -0.14 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):